All Participants | Control Participants | Athletes | p | |
---|---|---|---|---|
(n = 111) | (n = 41) | (n = 70) | ||
Age (years) | 20 (19.0–21.0) | 19 (18.0–20.0) | 20 (19.0–21.0) | 0.001 |
Weight (kg) | 66.6 (62.3–74.2) | 64.2 (58.1–68.4) | 68.4 (63.6–75.9) | 0.012 |
BMI (kg/m2) | 23.7 (22.2–25.6) | 21.7 (20.1–24.0) | 24.2 (23.2–26.0) | < 0.001 |
FMI (kg/m2) | 2.7 (2.3–3.7) | 3.2 (2.3–4.9) | 2.6 (2.2–3.5) | 0.024 |
SMI (kg/m2) | 11.9 (11.0–12.5) | 10.5 (9.9–11.5) | 12.4 (11.9–13.0) | < 0.001 |
TC (mg/dL) | 168 (150–186) | 171 (156–186) | 167 (145–186) | 0.452 |
LDL-C (mg/dL) | 94 (83–110) | 100 (85–115) | 93 (82–105) | 0.282 |
HDL-C (mg/dL) | 56 (51–66) | 53 (48–63) | 59 (53–67) | 0.016 |
TG (mg/dL) | 64 (49–81) | 66 (49–101) | 64 (49–76) | 0.288 |
LPL (ng/mL) | 62.5 (52.5–72.6) | 52.3 (47.6–59.0) | 67.3 (60.2–76.0) | < 0.001 |
GPIHBP1 (pg/mL) | 986 (853–1150) | 934 (742–1039) | 1038 (890–1283) | < 0.001 |
HTGL (ng/mL) | 44.1 (33.1–61.1) | 43.9 (34.6–61.3) | 45.5 (30.0–61.0) | 0.525 |
FT3 (pg/mL) | 3.22 (3.09–3.39) | 3.18 (3.04–3.34) | 3.23 (3.10–3.41) | 0.115 |
FT4 (ng/dL) | 1.04 (0.98–1.10) | 1.02 (0.98–1.10) | 1.05 (0.97–1.11) | 0.318 |
TSH (μIU/mL) | 1.78 (1.24–2.25) | 1.84 (1.19–2.12) | 1.67 (1.36–2.30) | 0.647 |